Michael X. Imbroscio

August 1, 2020, CNN

Michael Imbroscio’s role in the Clinton Administration during the impeachment process was highlighted by CNN. Mr. Imbroscio served as an Associate Counsel to the President.

February 4, 2020, Association of Business Trial Lawyers, Northern California

January 17, 2020

WASHINGTON—Am Law Litigation Daily has named Covington partner Michael Imbroscio, co-chair of the firm’s Product Liability and Mass Tort practice, as a “Litigator of the Week.” Mr. Imbroscio led the defense of Eli Lilly and Company in litigation alleging that its medicine Cialis – as well as Pfizer’s medicine Viagra – could cause melanoma, convincing the trial ...

January 13, 2020

WASHINGTON—The American Lawyer has named Covington as its Product Liability Litigation Department of the Year for the second time. The firm was also recognized as a finalist for the White Collar Department of the Year and “honorable mention” for general Litigation Department of the Year. In its profile, The American Lawyer highlights Covington’s product ...

December 29, 2019, The American Lawyer

June 3, 2019, The National Law Journal

June 3, 2019, The National Law Journal

May 28, 2019

WASHINGTON—The National Law Journal has named Covington one of three Washington, D.C. Litigation Departments of the Year. The firm was also named Product Liability/Mass Torts Department of the Year.   With the largest litigation practice in Washington, Covington won a “string of victories” that “solidified the firm’s reputation as an inside-the-Beltway ...

August 2, 2018, Covington Alert

On August 1, 2018, the New Jersey Supreme Court issued a unanimous decision affirming a trial court’s exclusion of scientifically unfounded expert causation testimony in the Accutane litigation. The decision, which ends over 2,100 lawsuits against Hoffmann-La Roche Inc. and Roche Laboratories Inc. (“Roche”), represents the Supreme Court’s first statement on New ...

May 10, 2018, Law360

Michael Imbroscio and Phyllis Jones were recognized as “Legal Lions” by Law360 for their victory on behalf of Boehringer Ingelheim in a second bellwether trial as part of a consolidated state proceeding over the alleged bleeding risk of its blood thinner Pradaxa. The jury rejected a woman’s claims that taking the drug landed her in the hospital.

January 30, 2018, Law360

Covington was named a 2017 Product Liability Practice Group of the Year by Law360. According to Paul Schmidt, "It's a pretty new group, relatively speaking, and a younger group. Our practice probably started 10 years ago and has really been completely built into a top-tier practice over that time-frame. … I think that gives us a certain nice energy." He adds ...

August 20, 2017, Law360

Law360 features Covington in an article examining how "firms are making substantial progress on diversifying their ranks." According to Anne Lee, "The firm is thoughtful about creating opportunities for developing attorneys, and that’s what has kept me here. It’s helping me grow.” Michael Imbroscio describes that firm's program where diverse recruits who have ...

April 16, 2017, The Litigation Daily

The Litigation Daily highlights Covington’s representation of Roche in the ongoing Accutane litigation, which recently saw a momentous defense ruling, likely leading to the dismissal of the nearly 3,000 remaining cases. Covington’s Product Liability team is led by Paul Schmidt and Michael Imbroscio.

February 10, 2017, Law360

Law360 selected Covington’s Life Sciences practice as a “Practice Group of the Year,” highlighting the firm’s involvement in billion-dollar transactions, success in contentious litigation, and regulatory advice on cutting-edge technology. According to Michael Labson, “What we offer and bring to complicated, complex issues is a mixture of deep subject-matter ...

February 7, 2017, Major, Lindsey & Africa

Michael Imbroscio is quoted in Major, Lindsey & Africa’s “Diversity Done Well” feature discussing Covington’s focus on diversity. According to Imbroscio, “Our clients are demanding diverse legal teams, so we need to be mindful of the fact that this is a business imperative and we need to be able to bring in strong, diverse lawyers.”  

January 17, 2017, Law360

Law360 selected Covington’s Product Liability practice as a “Practice Group of the Year,” profiling the team’s defense of Takata in litigation over potentially explosive airbags and Bayer Healthcare in multidistrict litigation (MDL) over Mirena IUDs, among other matters. According to Paul Schmidt, the firm’s range of work showcases its diversity of ...

January 3, 2017

WASHINGTON—Law360 has named six Covington lawyers as MVPs in their respective practice areas. The awards single out lawyers from across various practice areas based on their “success in high-stakes litigation, complex global matters, and record-breaking deals.” The Covington lawyers recognized as Law360 MVPs are: Shara Aranoff, International Trade. Ms. ...

December 21, 2016, Law360

Law360 selected Michael Imbroscio as a 2016 Product Liability MVP and profiled his mass tort defense victories over the past year, which scored notable wins for Eli Lilly, Roche, Bayer, and others. According to Imbroscio, “I think our success is driven by our ability to zero in on the key legal and factual issues in a case and drive the litigation to focus on ...

September 30, 2016, CHAM 2016: The Money of Healthcare System

September 21, 2016, ABA Life Sciences Legal Summit

August 12, 2016, Law360

John Hall, Paul Schmidt, Michael Imbroscio, and Stephen Anthony are quoted in the Law360 profile of the firm for the “Litigation Powerhouse” series. According to Hall, “What we have that other firms don't have is this incredible depth of regulatory and prior government experience that we bring to bear in almost all of our matters.” Schmidt, commenting on the ...

August 18, 2015, The Am Law Litigation Daily

Covington lawyers were recognized for winning their third trial in four weeks on behalf of Eli Lilly in the Cymbalta litigation. The latest victory occurred in the U.S. District Court for the Eastern District of Virginia after a six-day trial. The team included partners Michael Imbroscio, Phyllis Jones and Paul Schmidt.

August 14, 2015, The Am Law Litigation Daily

Phyllis Jones, Paul Schmidt, and Michael Imbroscio are quoted in an Am Law Litigation Daily article regarding their victory on behalf of client Eli Lilly in the Cymbalta litigation that looks closely at the cross-examination which exploited holes in plaintiff Erin Hexum’s case.  During Hexum’s questioning, Jones used personal details from prior testimony to ...

May 29, 2015

WASHINGTON, DC, May 29, 2015 — Law360 ranked Covington eighth on its list of “Top 25 Best Law Firms For Black Attorneys.” The list highlights firms that have significantly more black attorneys than the industry average, particularly at the partner level. According to the publication, the firms in the top 25 average 6.6 percent black non-partners and 4.4 percent ...

April 14, 2015

WASHINGTON, DC, April 14, 2015 — Am Law Litigation Daily named Covington’s Paul Schmidt and Michael Imbroscio “Litigators of the Week” for leading the defense of Hoffmann-La Roche in the extensive litigation over its acne medication Accutane. Mr. Schmidt and Mr. Imbroscio scored a major victory on April 2 when they convinced a New Jersey state court judge ...

April 10, 2015, Am Law's The Litigation Daily

Covington's Paul Schmidt and Michael Imbroscio were named "Litigators of the Week" by AmLaw for their successful representation of Hoffmann-La Roche Inc.: "Not so long ago, Hoffmann-La Roche Inc. faced a grim reality in sprawling litigation over the acne medication Accutane." "In 2007, New Jersey judge Carol Higbee handed an edge to plaintiffs lawyers at ...

April 9, 2015, InsideCounsel

Covington's Mike Imbroscio was interviewed by InsideCounsel regarding the firm's participation in the OnRamp program: “There was no good model in place to make it easy for attorneys who stay at home to re-enter the workplace,” says Michael Imbroscio, chair of diversity initiatives and hiring partner at the Washington, D.C., office of Covington & Burling. The ...

April 1, 2015

WASHINGTON, DC, April 1, 2015  — Covington is proud to participate in the OnRamp Fellowship, a program that provides women lawyers re-entering the legal profession with an opportunity to update their skills and legal contacts through one-year, paid positions with top law firms. The program aims to replenish the talent pipeline in law firms with diverse, ...

February 23, 2015, Reuters

Covington's Mike Imbroscio and Paul Schmidt are mentioned regarding their successful representation of Roche in convincing a New Jersey judge to reject the testimony of plaintiffs’ experts who had linked its acne medication Accutane to Crohn's disease.

December 22, 2014, American Lawyer

Covington's Michael Imbroscio, Mark Lynch and Phyllis Jones are mentioned in these articles regarding their successful representation of Eli Lilly & Co.

November 19, 2014

WASHINGTON, DC, November 19, 2014 — For the seventh consecutive year, the Human Rights Campaign Foundation has awarded Covington & Burling the top rating of 100 percent in the 2015 Corporate Equality Index. Covington’s rating reflects its support for same-sex partners of employees through health insurance, bereavement and family leave policies, as well as its ...

June 3, 2013

WASHINGTON, DC, June 3, 2013 — For the fifth time, The National Law Journal has named Covington & Burling to its “Appellate Hot List.” The 2013 list recognizes firms whose appellate track records over the past year have included significant victories in cases that affect the course of industries, vindicate important constitutional rights, and have high financial ...

March 14, 2013, Law360

December 3, 2012

WASHINGTON, DC, December 3, 2012 — Law360 named five Covington & Burling lawyers today as “Most Valuable Players” in their respective practice areas. The award singles out lawyers from across 22 practice areas whose achievements in major litigation or transactional matters have “raised the bar” over the past year. The Covington lawyers recognized as Law360 MVPs ...

December 2010, ACI Drug and Medical Device Conference

December 2009, ACI Drug and Medical Device Conference

June 2009, Drug Litigation Conference: Pharmaceutical Law and Preemption in a Post-Levine World

March 9, 2009, Covington E-Alert

December 2008, ACI Drug and Medical Device Conference

July 2008, ACI Drug and Device Preemption Conference

April 15, 2008, Covington E-Alert

4/9/2008

WASHINGTON, DC, April 9, 2008 — Covington & Burling LLP has been named to The National Law Journal’s inaugural “Appellate Hot List.” The “Hot List,” featured in the publication’s April 7 issue, recognizes 20 firms whose appellate track records included significant 2007 victories in cases with high financial stakes or that presented important legal principles. ...

February 27, 2008, Covington E-Alert

December 2007, ACI Drug and Medical Device Conference

July 17, 2007, Health Law 360

March 29, 2007, Covington E-Alert

2007, International Comparative Legal Guide to: Product Liability

January 2006, Presentation to Pharmaceutical Education & Research Institute

2005, 107 W. VA. L. REV. 847

2004, Presentation to ABA Litigation Group, Product Liability Committee

April 17, 2000, Legal Times

September 20, 1999, Legal Times